Guangdong Dongfang Precision Science&Technology Co.,Ltd.
Q3 2021 Report
Important Notes:
1. The Board of Directors (or the “Board”), the Supervisory Committee aswell as the directors, supervisors and senior management of GuangdongDongfang Precision Science & Technology Co., Ltd. (hereinafter referred to asthe “Company”) hereby guarantee that the contents of this Report are true,accurate and complete and free of any misrepresentations, misleadingstatements or material omissions, and collectively and individually accept legalresponsibility for such contents.
2. The Company’s legal representative, the Company’s Chief FinancialOfficer, and the Head of the Company’s Accounting Department (equivalent toFinancial Manager) hereby guarantee that the financial statements carried inthis Report are truthful, accurate and complete.
3. Whether the quarter report has been audited
□ Yes √ No
This Report has been prepared in Chinese and translated into English.Should there be any discrepancies or misunderstandings between the twoversions, the Chinese version shall prevail.
I Key Financial Information
1. Key Financial Data and Indicators
Indicate whether there is any retrospectively restated datum in the table below.
□ Yes √ No
The Company as well as all members of the Board of Directors hereby guarantee thatthe information disclosed is true, accurate and complete and free of any misrepresentations,misleading statements or material omissions.
Q3 2021 | Change(%) | Q1-Q3 2021 | Change(%) | |
Operating revenue (RMB yuan) | 1,071,169,589.35 | 38.31% | 2,471,728,553.53 | 26.63% |
Net profit attributable to the listed company’s shareholders (RMB yuan) | 129,754,201.64 | 31.70% | 320,871,722.10 | 42.16% |
Net profit attributable to the listed company’s shareholders before | 119,708,244.58 | 48.00% | 275,731,077.14 | 70.31% |
exceptional gains and losses (RMB yuan) | ||||
Net cash generated from/used in operating activities (RMB yuan) | —— | —— | 123,716,021.96 | -50.31% |
Basic earnings per share (RMB yuan /share) | 0.10 | 39.15% | 0.24 | 60.00% |
Diluted earnings per share (RMB yuan /share) | 0.10 | 39.15% | 0.24 | 60.00% |
Weighted average return on equity (%) | 3.28% | 1.06% | 7.95% | 2.72% |
30 September 2021 | 31 December 2020 | Change(%) | ||
Total assets (RMB) | 6,630,829,730.33 | 6,323,236,687.05 | 4.86% | |
Equity attributable to the listed company’s shareholders (RMB) | 4,014,149,425.76 | 4,158,538,499.75 | -3.47% |
2. Exceptional Gains and Losses
√ Applicable □ Not applicable
Unit: RMB yuan
Item | Q3 2021 | Q1-Q3 2021 | Notes |
Gain or loss on disposal of non-current assets (inclusive of impairment allowance write-offs) | 9,938.28 | 254,557.45 | |
Government grants through profit or loss (exclusive of government grants given in the Company’s ordinary course of business at fixed quotas or amounts as per the government’s uniform standards) | 2,032,349.64 | 8,744,677.29 | |
Gain or loss on fair-value changes on held-for-trading and derivative financial assets and liabilities & income from disposal of held-for-trading and derivative financial assets and liabilities and other debt investments (exclusive of the effective portion of hedges that arise in the Company’s ordinary course of business) | 6,630,606.98 | 38,167,876.92 | |
Non-Operating Revenue and expenses other than the above | 2,744,844.77 | 2,720,766.46 | |
Less: Income tax effects | 1,047,578.97 | 4,007,623.56 | |
Non-controlling interests effects (net of tax) | 324,203.64 | 739,609.60 | |
Total | 10,045,957.06 | 45,140,644.96 | -- |
Other items that meet the definition of Exceptional Gains and Losses:
□ Applicable √ Not applicable
No such cases for the Reporting Period.Explanation of why the Company reclassifies as recurrent an exceptional gain/loss item defined or listed in the ExplanatoryAnnouncement No. 1 on Information Disclosure for Companies Offering Their Securities to the Public—Exceptional Gain/LossItems:
□ Applicable √ Not applicable
No such cases for the Reporting Period.
3. Changes in Key Financial Data and Indicators and the Reasons
√Applicable □ Not applicable
Unit: RMB yuan
(1) Balance sheet items
Items | 30 September 2021 | 31 December 2020 | Change amount | Change(%) | Notes |
Cash and bank balances | 1,639,145,929.97 | 885,711,053.88 | 753,434,876.09 | 85.07% | Mainly due to the transfer of some large certificates of deposit and the recovery of some funds from wealth management products and securities investments during the period. |
Accounts receivable | 725,086,423.72 | 469,635,423.58 | 255,451,000.14 | 54.39% | Mainly due to the increase in sales during the period. |
Prepayments | 50,602,032.65 | 29,109,416.21 | 21,492,616.44 | 73.83% | Mainly due to the increase in orders, resulting in an increase in material purchases during the period. |
Current portion of non-current assets | 107,107,500.00 | 2,556,000.00 | 104,551,500.00 | 4090.43% | Mainly due to the reclassification of other non-current assets to current portion of non-current assets. |
Other non-current assets | 299,552,405.96 | 936,540,047.40 | -636,987,641.44 | -68.01% | Mainly due to the early redemption of other non-current assets and reclassification of other non-current assets to current portion of non-current assets during the period. |
Short-term borrowings | 371,830,802.69 | 39,533,281.84 | 332,297,520.85 | 840.55% | Mainly due to the addition of new short-term borrowings during the period. |
Tax payable | 60,331,362.40 | 36,369,777.05 | 23,961,585.35 | 65.88% | Mainly due to the increase in profit, resulting in an increase in tax payable during the period. |
Current portion of non-current liabilities | 40,894,679.18 | 226,597,528.74 | -185,702,849.56 | -81.95% | Mainly due to the repayment of part of the borrowings. |
Financial liabilities held for trading | 5,286,141.68 | 41,408,109.80 | -36,121,968.12 | -87.23% | Mainly due to the acquisition of minority interests during the period. |
Treasury stock | 59,060,125.60 | 579,403,185.12 | -520,343,059.52 | -89.81% | Mainly due to the retirement of repurchased shares during the period. |
(2) Income statement items
Items | Q1-Q3 2021 | Q1-Q3 2020 | Change amount | Change(%) | Notes |
R&D expenses | 72,900,003.34 | 53,663,442.74 | 19,236,560.60 | 35.85% | Mainly due to the increased investment in research and development during the period. |
Investment income | 83,707,643.47 | 53,526,100.78 | 30,181,542.69 | 56.39% | Mainly due to the increase in investment income recognized during the period. |
Gain/loss on changes in fair value | 19,786,150.60 | 10,224,490.31 | 9,561,660.29 | 93.52% | Mainly due to the increase in changes in fair value recognized for securities investment during the period. |
(3) Cash flow statement items
Items | Q1-Q3 2021 | Q1-Q3 2020 | Change amount | Change(%) | Notes |
Net cash generated from/used in operating activities | 123,716,021.96 | 248,985,657.24 | -125,269,635.28 | -50.31% | Mainly due to the increase in sales and accounts receivable, as well as the increase in orders and cash paid for inventory reserves during the period. |
Net cash generated from/used in investing activities | 981,796,242.31 | -304,321,178.06 | 1,286,117,420.37 | 422.62% | Mainly due to the recovery of a large amount of bank wealth management products during the period. |
II Shareholder Information
1. Total Number of Ordinary Shareholders and Number of Preference Shareholders with Resumed VotingRights, as well as Information of Top 10 Shareholders
Unit: shares
Number of ordinary shareholders at the period-end | 48,177 | Number of preference shareholders with resumed voting rights at the period-end (if any) | 0 | |||||
Top 10 shareholders | ||||||||
Name of shareholder | Nature of shareholder | Shareholding percentage | Total shares held at the period-end | Restricted shares held | Shares in pledge or frozen | |||
Status | Shares | |||||||
Tang Zhuolin | Domestic individual | 20.32% | 270,737,568 | 203,053,176 | In pledge | 187,000,000 | ||
Tang Zhuomian | Domestic individual | 7.27% | 96,885,134 | 0 | ||||
Pulead Technology Industry Co., Ltd. | State-owned corporation | 4.61% | 61,454,378 | 0 | ||||
Contemporary Amperex Technology Co., Ltd. | Domestic non-state-owned corporation | 3.36% | 44,757,468 | 0 | ||||
Luzhou Industrial Development Investment Group Co., Ltd. | State-owned corporation | 2.38% | 31,770,010 | 0 | ||||
Huarong Securities-China Merchants Securities-Huarong Youzhi Collective Asset Management Plan No. 1 | Other | 2.36% | 31,372,549 | 0 | ||||
Qiu Yezhi | Domestic individual | 2.34% | 31,176,518 | 23,382,388 | ||||
Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) | Domestic non-state-owned corporation | 2.00% | 26,628,340 | 0 | ||||
Liang Shujing | Domestic individual | 1.95% | 26,000,000 | 0 | ||||
JIC Investment Co., Ltd. | State-owned corporation | 1.94% | 25,896,385 | 0 | ||||
Top 10 unrestricted ordinary shareholders | ||||||||
Name of shareholder | Unrestricted shares held at the period-end | Shares by type | ||||||
Type | Shares | |||||||
Tang Zhuomian | 96,885,134 | RMB-denominated ordinary stock | 96,885,134 | |||||
Tang Zhuolin | 67,684,392 | RMB-denominated ordinary stock | 67,684,392 | |||||
Pulead Technology Industry Co., | 61,454,378 | RMB-denominated | 61,454,378 |
Ltd. | ordinary stock | ||
Contemporary Amperex Technology Co., Ltd. | 44,757,468 | RMB-denominated ordinary stock | 44,757,468 |
Luzhou Industrial Development Investment Group Co., Ltd. | 31,770,010 | RMB-denominated ordinary stock | 31,770,010 |
Huarong Securities-China Merchants Securities-Huarong Youzhi Collective Asset Management Plan No. 1 | 31,372,549 | RMB-denominated ordinary stock | 31,372,549 |
Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) | 26,628,340 | RMB-denominated ordinary stock | 26,628,340 |
Liang Shujing | 26,000,000 | RMB-denominated ordinary stock | 26,000,000 |
JIC Investment Co., Ltd. | 25,896,385 | RMB-denominated ordinary stock | 25,896,385 |
Hong Kong Securities Clearing Company Ltd. | 25,719,266 | RMB-denominated ordinary stock | 25,719,266 |
Related or acting-in-concert parties among the shareholders above | Mr. Tang Zhuolin and Mr. Tang Zhuomian are brothers. On 18 August 2010, they signed the Agreement on Acting in Concert. Pulead Technology Industry Co., Ltd. and Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) are acting-in-concert parties. Apart from that, the Company is not aware of any related or acting-in-concert parties among the other shareholders above. | ||
Top 10 shareholders involved in securities margin trading (if any) | As of 30 September 2021, Pulead Technology Industry Co., Ltd. held 61,454,256 shares in the Company in its client account of collateral securities for margin trading in China Securities Co., Ltd.; and Luzhou Industrial Investment Group Co., Ltd. held 31,770,010 shares in the Company in its client account of collateral securities for margin trading in Guotai Junan Securities Co., Ltd.; and Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) held 26,628,300 shares in the Company in its client account of collateral securities for margin trading in China Securities Co., Ltd.; and Liang Shujing held 26,000,000 shares in the Company in its client account of collateral securities for margin trading in China Securities Co., Ltd. |
2. Total Number of Preference Shareholders and Information of Top 10 Preference Shareholders
□ Applicable √ Not applicable
III Other Significant Events
√Applicable □ Not applicable
1. Launched a new phase of Share Repurchase Plan
On 22 September 2021, the Second Extraordinary General Meeting of 2021 considered and approved the Proposal on the sharerepurchase plan for 2021. The Company would repurchase its shares from the secondary market through centralized bidding tradingwith total self-owned funds of RMB500 million (inclusive) at least and RMB1 billion at most. The repurchase price would notexceed RMB8.34/share. The repurchased shares would be used for the following purposes: not less than 80% of the actual number ofrepurchased shares will be retired to reduce the Company's registered capital; not more than 20% of the actual number of repurchasedshares would be used for share incentive or employee stock ownership plan. The implementation period of the share repurchase planfor 2021 will be within 12 months from the date of approval of the share repurchase plan by the general meeting of the Company. Fordetails, please refer to the Report on Share Repurchase disclosed by the Company in China Securities Journal, Securities Times,Shanghai Securities News and the website of Shenzhen Stock Exchange on 23 September 2021.As of 30 September 2021, the Company's special securities account for the repurchase had not yet implemented any operationrelated to the repurchase of shares; as of the date of submission of this report for disclosure, a total of 13.7728 million shares (1.03%of the Company’s total share capital) were repurchased by way of centralized bidding, with a total payment of approximately
RMB78.3221 million (exclusive of transaction costs, highest transaction price: RMB5.94/share; lowest transaction price:
RMB5.53/share).
2. Repurchased and retired 150,000 incentive shares granted
On 22 September 2021, the Second Extraordinary General Meeting of 2021 considered and approved the Proposal on theRepurchase and Retirement of Certain Restricted Shares. In accordance with the relevant provisions of the Administrative Measures forShare Incentives of Listed Companies and the Company's Restricted Stock Incentive Plan 2020 (Draft) and the Evaluation Measuresfor the Implementation of the 2020 Restricted Share Incentive Plan of the Company, it was decided to repurchase and retire 150,000restricted shares, accounting for approximately 0.011% of the total share capital before this repurchase and retirement.On 26 October 2021, the repurchase and retirement of the above-mentioned restricted shares was completed by the Company. Fordetails, please refer to the Announcement on the Completion of the Repurchase and Retirement of Certain Restricted Shares disclosedby the Company in China Securities Journal, Securities Times, Shanghai Securities News and the website of Shenzhen StockExchange on 28 October 2021.IV Quarterly Financial Statements
1. Financial Statements
(1) Consolidated Balance Sheet
Prepared by: Guangdong Dongfang Precision Science & Technology Co., Ltd.
30 September 2021
Unit: RMB yuan
Item | 30 September 2021 | 31 December 2020 |
Current assets: | ||
Cash and bank balances | 1,639,145,929.97 | 885,711,053.88 |
Settlement provisions | ||
Dismantling funds | ||
Financial assets held for trading | 1,251,118,522.33 | 1,636,296,430.31 |
Derivative financial assets | ||
Notes receivable | 2,150,000.00 | 12,744,582.88 |
Accounts receivable | 725,086,423.72 | 469,635,423.58 |
Receivable financing | 48,177,648.24 | 56,737,978.04 |
Prepayments | 50,602,032.65 | 29,109,416.21 |
Premium receivable | ||
Receivable reinsurance account | ||
Provision for reinsurance contract receivable | ||
Other receivables | 64,642,396.69 | 79,103,472.64 |
Including: Interest receivable | 52,607.81 | 587,074.81 |
Dividend receivable | ||
Buy back resale financial assets | ||
Inventories | 936,091,610.69 | 734,120,595.26 |
Contract assets | 3,740,773.85 | 29,504,693.97 |
Assets held for sale |
Current portion of non-current assets | 107,107,500.00 | 2,556,000.00 |
Other current assets | 44,129,346.52 | 22,271,217.65 |
Total current assets | 4,871,992,184.66 | 3,957,790,864.42 |
Non-current assets: | ||
Loans and advances | ||
Debt investment | ||
Other debt investments | ||
Long-term receivables | 2,709,568.85 | 1,475,000.00 |
Long-term equity investment | 75,214,754.74 | 72,671,204.73 |
Investment in other equity instruments | ||
Other non-current financial assets | 5,810,936.18 | 5,948,588.15 |
Real estate investment | ||
Fixed assets | 546,866,099.25 | 571,413,480.14 |
Construction in progress | 9,642,024.94 | 9,062,038.52 |
Productive biological assets | ||
Oil and gas asset | ||
Right-of-use assets | 76,963,902.33 | |
Intangible assets | 310,450,632.30 | 332,387,182.69 |
Development expenditure | ||
Goodwill | 313,761,409.87 | 324,904,239.97 |
Long-term prepaid expenses | 13,500,557.43 | 12,096,981.78 |
Deferred tax assets | 104,365,253.82 | 98,947,059.25 |
Other non-current assets | 299,552,405.96 | 936,540,047.40 |
Total non-current assets | 1,758,837,545.67 | 2,365,445,822.63 |
Total assets | 6,630,829,730.33 | 6,323,236,687.05 |
Current liabilities: | ||
Short-term borrowings | 371,830,802.69 | 39,533,281.84 |
Borrowing from the Central Bank | ||
Borrowed funds | ||
Financial liabilities held for trading | 5,286,141.68 | 41,408,109.80 |
Derivative financial liabilities | ||
Notes payable | 135,203,732.09 | 104,855,187.97 |
Accounts payable | 603,239,540.38 | 503,042,561.05 |
Advance receivables | ||
Contract liabilities | 442,900,489.11 | 362,792,713.35 |
Selling back financial assets | ||
Deposits and Interbank deposit | ||
Agent trading securities | ||
Agent underwriting securities | ||
Employee benefits payable | 94,586,629.55 | 92,623,562.93 |
Tax payable | 60,331,362.40 | 36,369,777.05 |
Other payables | 81,706,281.37 | 81,743,851.64 |
Including: Interest payable | ||
Dividend payable | ||
Fees and commissions | ||
Reinsurance accounts payable | ||
Liabilities held for sale | ||
Current portion of non-current liabilities | 40,894,679.18 | 226,597,528.74 |
Other current liabilities | 13,943,644.50 | 20,532,046.04 |
Total current liabilities | 1,849,923,302.95 | 1,509,498,620.41 |
Non-current liabilities: | ||
Insurance contract reserve | ||
Long-term borrowings | 314,508,828.75 | 353,412,388.29 |
Bonds payable | ||
Including: Preference Shares | ||
Perpetual bonds | ||
Lease liabilities | 60,211,850.35 | |
Long-term payables | ||
Long-term employee benefits payable | 16,433,073.29 | 18,451,652.74 |
Provisions | 111,632,160.42 | 105,450,257.63 |
Deferred income | 15,800,747.80 | 16,861,488.27 |
Deferred tax liabilities | 24,402,237.79 | 19,296,386.16 |
Other non-current liabilities | 64,452,140.63 | 68,737,415.25 |
Total non-current liabilities | 607,441,039.03 | 582,209,588.34 |
Total Liabilities | 2,457,364,341.98 | 2,091,708,208.75 |
Equity: | ||
Share capital | 1,332,088,167.00 | 1,545,126,957.00 |
Other equity instruments | ||
Including: Preference Shares | ||
Perpetual bonds | ||
Capital surplus | 3,257,219,586.52 | 4,002,393,061.81 |
Less: Treasury stock | 59,060,125.60 | 579,403,185.12 |
Other comprehensive income | -8,128,633.78 | 20,026,089.70 |
Special reserve | 10,820,572.13 | 10,057,438.97 |
Surplus reserves | 51,830,974.45 | 51,830,974.45 |
General risk preparation | ||
Retained earnings | -570,621,114.96 | -891,492,837.06 |
Total equity attributable to owners of the parent | 4,014,149,425.76 | 4,158,538,499.75 |
Non-controlling interests | 159,315,962.59 | 72,989,978.55 |
Total equity | 4,173,465,388.35 | 4,231,528,478.30 |
Total liabilities and equity | 6,630,829,730.33 | 6,323,236,687.05 |
Legal representative: Tang Zhuolin Chief in charge of accounting work: Shao Yongfeng Head of accounting institution: Yao Bin
(2) Consolidated Income Statement for Q1-Q3
Unit: RMB yuan
Item | Q1-Q3 2021 | Q1-Q3 2020 |
1 Total operating revenue | 2,471,728,553.53 | 1,951,958,904.48 |
Including: Operating revenue | 2,471,728,553.53 | 1,951,958,904.48 |
Interest income | ||
Premiums earned | ||
Fee and commission income | ||
2 Total operating cost | 2,179,275,730.20 | 1,765,794,712.34 |
Including: Cost of sales | 1,755,193,255.34 | 1,399,258,221.80 |
Interest expense | ||
Payment of fees and commission | ||
Surrender fund | ||
Net indemnity expenditure | ||
Draw the net reserve of insurance liability contract | ||
Policy dividend expense | ||
Reinsurance cost | ||
Taxes and surcharges | 8,315,762.65 | 7,793,560.64 |
Selling expenses | 148,295,933.98 | 120,806,685.92 |
Administrative expenses | 201,190,092.94 | 184,551,546.73 |
R&D expenses | 72,900,003.34 | 53,663,442.74 |
Finance costs | -6,619,318.05 | -278,745.49 |
Including: Interest expenses | 8,801,348.95 | 10,237,015.64 |
Interest income | 18,468,389.42 | 16,848,399.62 |
Add: Other income | 8,886,009.32 | 8,423,825.78 |
Investment income (loss with "-" sign) | 83,707,643.47 | 53,526,100.78 |
Including: Share of profit or loss of joint ventures and associates | 2,653,965.06 | 198,549.36 |
Income from derecognition of financial assets measured at amortised cost (loss with "-" sign) | ||
Exchange gain (loss with "-" sign) | ||
Net exposure hedging gain (loss with "-" sign) | ||
Gain/loss on changes in fair value (loss with "-" sign) | 19,786,150.60 | 10,224,490.31 |
Credit impairment loss (loss is listed with "-" sign) | 1,177,069.04 | -1,384,648.98 |
Asset impairment loss (loss with "-" sign) | -3,577,852.62 | -2,073,080.91 |
Gain/loss on disposal of assets (loss with | 254,557.45 | -2,291.96 |
"-" sign) | ||
3 Operating profit (losses are listed with "-" sign) | 402,686,400.59 | 254,878,587.16 |
Add: Non-operating income | 3,624,142.99 | 2,106,749.39 |
Less: Non-operating expenses | 903,376.53 | 1,517,800.08 |
5 Gross profit (the gross loss shall be filled in with the sign "-") | 405,407,167.05 | 255,467,536.47 |
Less: Income tax expenses | 68,984,134.76 | 25,869,561.72 |
Net profit (net loss is listed with "-" sign) | 336,423,032.29 | 229,597,974.75 |
(1) Net profit from continuing operations | ||
i. Net profit from continuing operations (net loss with "-" sign) | 336,423,032.29 | 229,597,974.75 |
ii. Net profit from termination of operation (net loss with "-" sign) | ||
(2) Net profit classified by attribution of ownership | ||
i. Net profit attributable to owners of the parent | 320,871,722.10 | 225,718,052.39 |
ii. Net profit attributable to non-controlling interests | 15,551,310.19 | 3,879,922.36 |
6 Other comprehensive income/(loss), net of tax | -31,058,230.51 | -1,816,973.90 |
Other comprehensive income/(loss) attributable to owners of the parent, net of tax | -28,154,723.48 | -1,816,973.90 |
(1) Other comprehensive loss that will not be reclassified to profit or loss | -191,341.26 | 65,719.32 |
i. Changes caused by remeasurements on defined benefit schemes | -191,341.26 | 65,719.32 |
ii. Other comprehensive income that cannot be transferred to profit or loss under the equity method | ||
iii. Changes in fair value of investments in other equity instruments | ||
iv. Fair value change of enterprise's own credit risk | ||
v. Other | ||
(2) Other comprehensive income/(loss) that will be reclassified to profit or loss | -27,963,382.22 | -1,882,693.22 |
i. Other comprehensive income that can be transferred to profit or loss under the equity method | ||
ii. Changes in fair value of other debt investments | ||
iii. The amount of financial assets reclassified to other comprehensive income | ||
iv. Provision for credit impairment of other debt investments |
v. Cash flow hedging reserve | ||
vi. Differences arising from the translation of foreign currency-denominated financial statements | -27,963,382.22 | -1,882,693.22 |
vii. Other | ||
Other comprehensive income attributable to non-controlling interests, net of tax | -2,903,507.03 | |
Total comprehensive income | 305,364,801.78 | 227,781,000.85 |
Total comprehensive income attributable to owners of the parent | 292,716,998.62 | 223,901,078.49 |
Total comprehensive income attributable to non-controlling interests | 12,647,803.16 | 3,879,922.36 |
Earnings per share: | ||
(1) Basic earnings per share | 0.24 | 0.15 |
(2) Diluted earnings per share | 0.24 | 0.15 |
Legal representative: Tang Zhuolin Chief in charge of accounting work: Shao Yongfeng Head of accounting institution: Yao Bin
(3) Consolidated Statement of Cash Flows for Q1-Q3
Unit: RMB yuan
Item | Q1-Q3 2021 | Q1-Q3 2020 |
1 Cash flows from operating activities: | ||
Proceeds from sale of goods and rendering of services | 2,382,779,347.81 | 2,191,344,316.36 |
Net increase in customer deposits and interbank deposits | ||
Net increase in borrowing from the central bank | ||
Net increase in funds transferred to other financial institutions | ||
Cash received from the premium of the original insurance contract | ||
Net cash received from reinsurance business | ||
Net increase in depositors' deposits and investment funds | ||
Cash that collects interest, commission and commission | ||
Net increase in borrowed funds | ||
Net increase in funds for repurchase business | ||
Net cash received by agents buying and selling securities | ||
Receipts of taxes and surcharges refunds | 40,051,710.51 | 27,067,794.23 |
Cash generated from other operating activities | 39,581,691.59 | 141,235,719.07 |
Subtotal of cash generated from operating activities | 2,462,412,749.91 | 2,359,647,829.66 |
Payments for goods and services | 1,630,409,017.32 | 1,370,823,824.55 |
Net increase in customer loans and advances | ||
Net increase in central bank and interbank deposits | ||
Cash to pay the indemnity of the original insurance contract | ||
Net increase in loan funds | ||
Cash for the payment of interest, fees and commissions | ||
Cash for the payment of policy dividends | ||
Cash payments to and on behalf of employees | 409,726,364.04 | 390,338,827.65 |
Payments of all types of taxes and surcharges | 64,912,293.11 | 65,884,267.48 |
Cash used in other operating activities | 233,649,053.48 | 283,615,252.74 |
Subtotal of cash used in operating activities | 2,338,696,727.95 | 2,110,662,172.42 |
Net cash generated from/used in operating activities | 123,716,021.96 | 248,985,657.24 |
2 Cash flows from investing activities: | ||
Proceeds from disinvestment | 4,446,989,916.65 | |
Investment income | 94,953,231.61 | 53,327,551.42 |
Net proceeds from the disposal of fixed assets, intangible assets and other long-lived assets | 584,797.70 | 5,898.53 |
Disposal of net cash received by subsidiaries and other business units | ||
Cash generated from other investing activities | 2,434,405.65 | 6,263,980,802.74 |
Subtotal of cash generated from investing activities | 4,544,962,351.61 | 6,317,314,252.69 |
Payments for the acquisition of fixed assets, intangible assets and other long-lived assets | 45,944,656.39 | 97,690,291.05 |
Payments for investments | 3,517,221,452.91 | 1,185,720.00 |
Net increase in pledged loans | ||
Obtain net cash paid by subsidiaries and other business units | ||
Cash used in other investing activities | 6,522,759,419.70 | |
Subtotal of cash used in investing activities | 3,563,166,109.30 | 6,621,635,430.75 |
Net cash generated from/used in investing activities | 981,796,242.31 | -304,321,178.06 |
3 Cash flows from financing activities: | ||
Absorb the cash received by the investment | 100,000,000.00 | 22,600,000.00 |
Including: the subsidiary absorbs the cash received from the investment of minority shareholders | ||
Borrowings raised | 415,719,289.31 | 354,759,673.90 |
Cash generated from other financing activities | 89,711,220.71 | 124,187,890.90 |
Subtotal of cash generated from financing activities | 605,430,510.02 | 501,547,564.80 |
Repayment of borrowings | 286,140,449.72 | 441,132,461.88 |
Interest and dividends paid | 9,190,374.80 | 9,283,802.67 |
Including: Interest and dividends paid to minority shareholders | ||
Cash used in other financing activities | 970,497,565.95 | 596,361,181.41 |
Subtotal of cash used in financing activities | 1,265,828,390.47 | 1,046,777,445.96 |
Net cash generated from/used in financing activities | -660,397,880.45 | -545,229,881.16 |
4 Effect of foreign exchange rates changes on cash and cash equivalents | -30,078,848.75 | -8,508,042.88 |
5 Net (decrease)/increase in cash and cash equivalents | 415,035,535.07 | -609,073,444.86 |
Add: Cash and cash equivalents, beginning of the period | 860,601,236.78 | 2,226,724,737.39 |
6 Cash and cash equivalents, end of the period | 1,275,636,771.85 | 1,617,651,292.53 |
2. Explanation of the Adjustment of Financial Statements
(1) The adjustments to relevant items in the financial statements at the beginning of 2021 when the NewLease Standard was implemented for the first time
√ Applicable □ Not applicable
Whether to adjust the items in the balance sheets at the beginning of the year.
√ Yes □ No
Consolidated Balance Sheet
Unit: RMB yuan
Item | 31 December 2020 | 1 January 2021 | Adjustments |
Current assets: | |||
Cash and bank balances | 885,711,053.88 | 885,711,053.88 | |
Settlement provisions | |||
Dismantling funds | |||
Financial assets held for trading | 1,636,296,430.31 | 1,636,296,430.31 | |
Derivative financial assets | |||
Notes receivable | 12,744,582.88 | 12,744,582.88 | |
Accounts receivable | 469,635,423.58 | 469,635,423.58 | |
Receivable financing | 56,737,978.04 | 56,737,978.04 | |
Prepayments | 29,109,416.21 | 29,109,416.21 | |
Premium receivable | |||
Receivable reinsurance account | |||
Provision for reinsurance contract receivable | |||
Other receivables | 79,103,472.64 | 79,103,472.64 |
Including: Interest receivable | 587,074.81 | 587,074.81 | |
Dividend receivable | |||
Buy back resale financial assets | |||
Inventories | 734,120,595.26 | 734,120,595.26 | |
Contract assets | 29,504,693.97 | 29,504,693.97 | |
Assets held for sale | |||
Current portion of non-current assets | 2,556,000.00 | 2,556,000.00 | |
Other current assets | 22,271,217.65 | 22,271,217.65 | |
Total current assets | 3,957,790,864.42 | 3,957,790,864.42 | |
Non-current assets: | |||
Loans and advances | |||
Debt investment | |||
Other debt investments | |||
Long-term receivables | 1,475,000.00 | 1,475,000.00 | |
Long-term equity investment | 72,671,204.73 | 72,671,204.73 | |
Investment in other equity instruments | |||
Other non-current financial assets | 5,948,588.15 | 5,948,588.15 | |
Real estate investment | |||
Fixed assets | 571,413,480.14 | 571,413,480.14 | |
Construction in progress | 9,062,038.52 | 9,062,038.52 | |
Productive biological assets | |||
Oil and gas asset | |||
Right-of-use assets | 93,513,747.81 | 93,513,747.81 | |
Intangible assets | 332,387,182.69 | 332,387,182.69 | |
Development expenditure | |||
Goodwill | 324,904,239.97 | 324,904,239.97 | |
Long-term prepaid expenses | 12,096,981.78 | 12,096,981.78 | |
Deferred tax assets | 98,947,059.25 | 98,947,059.25 | |
Other non-current assets | 936,540,047.40 | 936,540,047.40 | |
Total non-current assets | 2,365,445,822.63 | 2,458,959,570.44 | 93,513,747.81 |
Total assets | 6,323,236,687.05 | 6,416,750,434.86 | 93,513,747.81 |
Current liabilities: | |||
Short-term borrowings | 39,533,281.84 | 39,533,281.84 | |
Borrowing from the Central Bank | |||
Borrowed funds | |||
Financial liabilities held for trading | 41,408,109.80 | 41,408,109.80 | |
Derivative financial liabilities | |||
Notes payable | 104,855,187.97 | 104,855,187.97 | |
Accounts payable | 503,042,561.05 | 503,042,561.05 | |
Advance receivables | |||
Contract liabilities | 362,792,713.35 | 362,792,713.35 | |
Selling back financial assets | |||
Deposits and Interbank deposit |
Agent trading securities | |||
Agent underwriting securities | |||
Employee benefits payable | 92,623,562.93 | 92,623,562.93 | |
Tax payable | 36,369,777.05 | 36,369,777.05 | |
Other payables | 81,743,851.64 | 81,743,851.64 | |
Including: Interest payable | |||
Dividend payable | |||
Fees and commissions | |||
Reinsurance accounts payable | |||
Liabilities held for sale | |||
Current portion of non-current liabilities | 226,597,528.74 | 226,597,528.74 | |
Other current liabilities | 20,532,046.04 | 20,532,046.04 | |
Total current liabilities | 1,509,498,620.41 | 1,509,498,620.41 | |
Non-current liabilities: | |||
Insurance contract reserve | |||
Long-term borrowings | 353,412,388.29 | 353,412,388.29 | |
Bonds payable | |||
Including: Preference Shares | |||
Perpetual bonds | |||
Lease liabilities | 93,513,747.81 | 93,513,747.81 | |
Long-term payables | |||
Long-term employee benefits payable | 18,451,652.74 | 18,451,652.74 | |
Provisions | 105,450,257.63 | 105,450,257.63 | |
Deferred income | 16,861,488.27 | 16,861,488.27 | |
Deferred tax liabilities | 19,296,386.16 | 19,296,386.16 | |
Other non-current liabilities | 68,737,415.25 | 68,737,415.25 | |
Total non-current liabilities | 582,209,588.34 | 675,723,336.15 | 93,513,747.81 |
Total Liabilities | 2,091,708,208.75 | 2,185,221,956.56 | 93,513,747.81 |
Equity: | |||
Share capital | 1,545,126,957.00 | 1,545,126,957.00 | |
Other equity instruments | |||
Including: Preference Shares | |||
Perpetual bonds | |||
Capital surplus | 4,002,393,061.81 | 4,002,393,061.81 | |
Less: Treasury stock | 579,403,185.12 | 579,403,185.12 | |
Other comprehensive income | 20,026,089.70 | 20,026,089.70 | |
Special reserve | 10,057,438.97 | 10,057,438.97 | |
Surplus reserves | 51,830,974.45 | 51,830,974.45 | |
General risk preparation | |||
Retained earnings | -891,492,837.06 | -891,492,837.06 | |
Total equity attributable to owners of the parent | 4,158,538,499.75 | 4,158,538,499.75 | |
Non-controlling interests | 72,989,978.55 | 72,989,978.55 | |
Total equity | 4,231,528,478.30 | 4,231,528,478.30 |
Total liabilities and equity | 6,323,236,687.05 | 6,416,750,434.86 | 93,513,747.81 |
(2) Retrospective adjustments to the previous comparative data when the New Lease Standard wasimplemented for the first time
□Applicable √Not applicable
3. Audit Report
Whether the quarter report has been audited
□ Yes √ No
The quarter report has not been audited.
Board of Directors ofGuangdong Dongfang Precision Science&Technology Co.,Ltd.
28 October 2021